Endovascular treatment of infrapopliteal arteries: Angioplasty vs stent in the drug-eluting era

European Radiology

Volumn 24, Issue 4, 2014, Pages 793-798

  Fanelli, Fabrizio ^a   Cannavale, Alessandro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

ARTICLE; BALLOON DILATATION; BARE METAL STENT; CARDIOVASCULAR THERAPEUTIC DEVICE; COMPARATIVE STUDY; CRITICAL LIMB ISCHEMIA; DISEASE REGISTRY; DRUG ELUTING BALLOON; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; LIMB SALVAGE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; SURVIVAL RATE; VASCULAR DISEASE; VASCULAR PATENCY;

ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ARTERIES; DRUG-ELUTING STENTS; HUMANS; LEG; LIMB SALVAGE; PERIPHERAL ARTERIAL DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84896317694     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3094-0     Document Type: Article

References (22)

1. Reekers JA, Lammer J (2012) Diabetic foot and PAD: the endovascular approach. Diabetes Metab Res Rev 28:36-39
2. Peregrin JH, Koznar B, Kovàc J et al (2010) PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 33:720-725
3. Faglia E, Clerici G, Clerissi J et al (2007) When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischaemia. Diabet Med 24:823-829 (Pubitemid 47096589)
4. Park SW, Kim JS, Yun IJ et al (2013) Clinical outcomes of endovascular treatments for critical limb ischemia with chronic total occlusive lesions limited to below-the-knee arteries. Acta Radiol 54: 785-789
5. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A (2010) Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol 55:1580-1589
6. Rand T, Uberoi R (2013) Current status of interventional radiology treatment of infrapopliteal arterial disease. Cardiovasc Intervent Radiol 36:588-598
7. Rooke TW, Hirsch AT, Misra S et al (2011) 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 58:2020-2045
8. Gertz ZM,Wilensky RL (2011) Local drug delivery for treatment of coronary and peripheral artery disease. Cardiovasc Ther 29:e54-e66
9. Bosiers M, Scheinert D, Peeters P et al (2012) Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 55:390-398
10. Rastan A, Brechtel K, Krankenberg H et al (2012) Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol 60:587-591
11. Scheinert D, Katsanos K, Zeller T et al (2012) A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol 60:2290-2295
12. Bradbury AW, Adam DJ, Bell J et al (2010) Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Health Technol Assess 14:1-210
13. Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45:1-67
14. Siablis D, Karnabatidis D, Katsanos K et al (2009) Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 20:1141-1150
15. Karnabatidis D, Spiliopoulos S, Diamantopoulos A et al (2011) Primary everolimus-eluting stenting versus balloon angioplasty with bailout baremetal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 18:1-12
16. Tendera M, Aboyans V, Bartelink ML et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32:2851-2906
17. Katsanos K, Karnabatidis D, Diamantopoulos A, Spiliopoulos S, Siablis D (2013) Cost-effectiveness analysis of infrapopliteal drug eluting stents. Cardiovasc Intervent Radiol 36:90-97
18. Schmidt A, Piorkowski M, Werner M et al (2011) First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 58:1105-1109
19. Schmidt A, Ulrich M, Winkler B et al (2010) Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 76:1047-1054
20. Fanelli F, Cannavale A, Boatta E et al (2012) Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther 19:571-580
21. Fanelli F, Cannavale A, Lucatelli P et al (2013) Lower limb multilevel treatment with drug eluting balloon: 12-month results from the "DEBELLUM" trial. Proc ECR 2013, Vienna
22. Liistro F, Porto I, Angioli P et al (2013) Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 128:615-621